
CEO
Gideon Petrover
Partner in Om-Maya, a private equity firm. Management experience in a multinational corporation, with a focus on management and operations, and information management.
The management team, the board of directors and the scientific advisors behind Nanomedic.

CEO
Partner in Om-Maya, a private equity firm. Management experience in a multinational corporation, with a focus on management and operations, and information management.

CTO
Dr. Barzilay has over 20 years of recognized research and development experience in the field of Pharma, Biotech, and Medical Devices. Before joining Nanomedic, Claudia served as Project Manager, Scientific Advisor, and VP R&D in local and global biotech and cleantech companies, gaining broad knowledge in Product Development. She received her Ph.D. in Chemistry from the Technion - Israel Institute of Technology, pursued postdoctoral research at Stanford University, CA, USA, and achieved a Researcher and Lecturer position at the Faculty of Medicine, Hebrew University of Jerusalem.

VP Finance
Mr. Morris has more than 25 years of managerial, financial, and operations experience and has expertise in complex financial arrangements dealing with private investment, disposition of assets, WOFEs, and joint ventures. Chanan has spent the last 16 years managing many of the Infinity group's top portfolio companies, and today also serves as the CFO of Imed Infinity Medical (TASE: IMED). Chanan holds a BSc in Accounting from Northeastern University (USA).

VP QA/RA
Mr. Zilberstein has more than 24 years of experience in the establishment and management of quality and regulatory assurance activities in the global medical device industry.
Before joining Nanomedic, Asher served as the QA/RA leader in several medical device companies, such as Endospan (endovascular aortic repair system), and Edwards' acquired Valtech Cardio (transcatheter repair of heart valves). Asher holds a Master of Science (MSc) in Biotechnology from the Hebrew University in Jerusalem, Israel.

Head of Global Sales & Marketing
Dr. Roni Koren brings over 20 years of global experience in business development, marketing, and commercial strategy across healthcare, life sciences, and technology. She specializes in translating breakthrough medical innovations into scalable, market-ready solutions.
Roni has led successful go-to-market efforts for digital health and medtech ventures across Europe, the U.S., APAC, and Israel, building strategic partnerships and investor relations that generated multi-million dollar pipelines.

VP Clinical and US Regulation
Liron holds a Ph.D. in Chemical Engineering and brings nearly 20 years of experience in the medical device and drug–device combination product space. As a senior executive and trusted member of leadership teams, she possesses multidisciplinary expertise across medical, software, hardware, and regulatory domains.

Operation manager
Lior holds a BSc in Biotechnology Engineering and an MSc in Environmental Engineering. He brings more than 14 years of experience in manufacturing, operations, and logistics management, with a strong focus on process optimization and organizational efficiency.

Active Chairman
The CEO of TechnoPlus Venture, a diversified public investment company, has traded on the Tel-Aviv Stock Exchange (TASE: TNPV) since 1999. Mr. Chen Katz possesses extensive experience in managing investments in companies and ventures of all maturity levels.

Director
A seasoned private equity investor and business leader with extensive experience in investing and listing companies on the NSE, Shanghai, Singapore and NASDAQ exchanges.

Director
Technologist & Investor with 20+ years of leadership experience with Fortune 500 companies like Robert Bosch & Stanley Black + Decker. Currently managing a portfolio of investments in the Med-Tech, Ed-Tech & Green-tech segments.

CEO
Partner in Om-Maya, a private equity firm. Management experience in a multinational corporation, with a focus on management and operations, and information management.

Director
Accomplished leadership coach in Business Strategy and Business Transformation, and professor of practice in Change Management, teaching at leading business schools in India, China, and Australia.

Scientific advisor
Prof. Dr. Josef Haik (born 1966, Ramat Gan, Israel) is a specialist in Aesthetic & Reconstruction Plastic Surgery and Burns. Prof Haik is the director of the National Intensive Care Burn Unit and Director of the Division of Plastic & Reconstructive Surgery at the Sheba Medical Center, Tel Hashomer Hospital, Ramat Gan, Israel, affiliated with Tel Aviv University. Prof. Haik is a Professor in the Faculty of Surgery at Tel Aviv University. Prof Haik completed his medical studies in 1994 at the University of Bologna, Italy, and has been a specialist in plastic surgery since 2002. Prof Haik completed a fellowship in Plastic Surgery in Sao Paulo, Brazil, and in the ICU, Burns in the Hospital of the University of Alberta, Canada. Prof. Haik has a Master's Degree in Public Health (MPH), disaster management since 2008. Prof Haik is a member and chairman of the American Burn Association. He is a member of the Israeli Association for Aesthetic Plastic Surgery, the Israel Medical Association, the International Association for Aesthetic Surgery, and the Israeli Association for Healing Wounds.

Scientific advisor
Prof. Plock currently serves as Chief of Plastic Surgery and Hand Surgery at the Aarau Canton Hospital (KSA), the largest hospital in the Aargau region, and one of the three largest hospital centers in Switzerland. He previously served in multiple roles at University Hospital Zurich, including Director of the Burn Center, Director of the Reconstructive Transplantation Program, and Director of the Post-Bariatric Body-Contouring Program. He was made a Fellow of the European Board of Plastic Surgeons in 2009 and earned his Adjunct Professorship from the University of Zurich in 2020.

Scientific advisor
With more than 35 years of experience, Dr. Harper currently serves as a Senior Medical Scientist in the Medical Solutions Division of 3M Health Care, where he is responsible for early-stage discovery and innovation related to advanced wound care. Dr. Harper previously served as Chief Technology Officer for KCI. In this 3M affiliate, he was responsible for innovation and technology development at the company's Center for Advanced Research and Technology. He also served as Vice President of Clinical Development and Clinical Sciences at biotechnology company LifeCell Corporation. Dr. Harper earned his Ph.D. in Biochemistry from the University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center.